The plasticity of CAFs in pancreatic cancer is mediated by transcription factor Prrx1, which is critical in CAF activation, in allowing a dynamic switch between a dormant and an activated state, and in exerting a significant impact on pancreatic cancer biology and therapeutic resistance [223]. This evidence concerns the gene PRRX1 and familial pancreatic carcinoma.